FDA Slams Zoll Over Defibrillator Battery Life Issues
The U.S. Food and Drug Administration unveiled a letter Tuesday blasting Zoll Medical Corp.'s response to problems over the battery life of its defibrillators....To view the full article, register now.
Already a subscriber? Click here to view full article